Technology News and Research

RSS

Study may spur research into multi-model imaging based biomarker development for AD

Alzheimer's disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide. In the last decade, research has advanced our understanding of how AD affects the brain. However, diagnosis continues to rely primarily on neuropsychological tests which can only detect the disease after clinical symptoms begin. In a supplement to the Journal of Alzheimer's Disease, investigators report on the development of imaging-based biomarkers that will have an impact on diagnosis before the disease process is set in motion.

31 Aug 2012

Scientists identify specific role of RESA protein in modulating blood circulation

When the parasite responsible for malaria infects human red blood cells, it launches a 48-hour remodeling of the host cells. During the first 24 hours of this cycle, a protein called RESA undertakes the first step of renovation: enhancing the stiffness of the cell membranes.

31 Aug 2012

Astellas Pharma adopts Advantest’s terahertz spectroscopic imaging system TAS7500

Advantest Corporation today announced that its terahertz spectroscopic imaging system TAS7500, which utilizes Advantest's THz wave technology, has been adopted by Astellas Pharma Inc.

31 Aug 2012

Glaucoma and cell death: an interview with Dr. Vivek Gupta

Glaucoma is normally caused by increased pressure of aqueous humour fluid in the eye. A defining feature of this disease is destruction of a particular type of cells in the retina called retinal ganglion cells and excavation of the optic disc region.

31 Aug 2012

Soligenix’s RiVax induces greater ricin neutralizing antibody levels in humans

Soligenix, Inc., a development stage biopharmaceutical company, announced today the results of a Phase 1B clinical trial of an aluminum hydroxide (Alum) adjuvanted formulation of RiVax, designed to improve the immunogenicity of the vaccine.

31 Aug 2012

Quest Diagnostics announces availability of TERC test for cervical cancer

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer.

From Quest Diagnostics 31 Aug 2012

MGC Diagnostics third quarter total revenues increase 8% to $6.9 million

MGC Diagnostics Corporation, a global medical technology company, today reported financial results for the third quarter of fiscal year 2012, ended July 31, 2012.

31 Aug 2012

Early European TAVI registry data unveiled

The 1-month follow-up results of the Transcatheter Valve Treatment Sentinel Pilot Registry have provided data on factors associated with transcatheter aortic valve implantation, as well as short term outcomes, in Europe.

30 Aug 2012

New book on medical screening to be launched on Sep. 4

Delegates from around the world will gather for the launch of a new book on medical screening edited by University of Leicester academics.

30 Aug 2012

Ambassador Rice lauds India's role in fighting polio, ensuring child survival

U.S. Permanent Representative to the United Nations Ambassador Susan Rice on Tuesday spoke at a reception at the U.S. Embassy in India meant "to highlight the Call to Action initiative against child mortality," Zee News reports.

30 Aug 2012

Bradykinesia in Parkinson’s disease: an interview with Dr. Joseph Giuffrida, President of Great Lakes NeuroTechnologies

Currently in the United States, there are over 1.5 million people living with Parkinson's and 50,000 new cases reported each year

30 Aug 2012

India's contribution to global health R&D needs domestic, international support

As the BRIC countries -- Brazil, Russia, India, and China -- invest more in innovations in health technologies and other areas, "many are looking to these countries to correct the global health research and development (R&D) imbalance that leaves the poor without needed products such as an improved tuberculosis (TB) vaccine or tests to help diagnose patients in remote rural settings," David de Ferranti, president of Results for Development Institute (R4D), writes in the Huffington Post Blog.

30 Aug 2012

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

A study published in the most recent issue of the Journal of the American Medical Association (JAMA) presented encouraging news regarding physicians' ability to determine blood flow and associated coronary artery disease (CAD) using noninvasive CT scanning technology.

30 Aug 2012

Octogenarians have better survival rates following heart valve surgery

Octogenarians need not shy away from heart valve surgery because of their age; however, those sent home following surgery do better than those discharged to care facilities, according to an observational study published in the September 2012 issue of The Annals of Thoracic Surgery.

30 Aug 2012

Johns Hopkins team creates synthetic protein that can help locate tumors

Johns Hopkins researchers have created a synthetic protein that, when activated by ultraviolet light, can guide doctors to places within the body where cancer, arthritis and other serious medical disorders can be detected.

30 Aug 2012

CCE, Accretive Health partner to develop novel oncology care management

Accretive Health, Inc., a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.

30 Aug 2012

UCSF’s intensive care unit study receives $2.1 million Moore Foundation grant

A multi-center study of intensive care units (ICU) led by UCSF faculty has received a Gordon and Betty Moore Foundation grant of $2.1 million. The study of ICUs, including two at UCSF, aims to better understand the nature of team-based care and patient involvement in ICU settings.

30 Aug 2012

Collegium commences enrollment in Oxycodone DETERx Phase 3 study in chronic lower back pain

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain today announced that it has initiated enrollment in its Phase 3 clinical study for Oxycodone DETERx (COL-003).

30 Aug 2012

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Medgenics, Inc., the developer of Biopump, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Israel's Ministry of Health (MOH) has approved two Phase I/II clinical trials to assess the safety and efficacy of INFRADURE in patients with hepatitis C.

30 Aug 2012

Lilly decides to terminate pomaglumetad methionil Phase III trial on schizophrenia

Eli Lilly and Company announced today the decision to stop ongoing clinical studies investigating pomaglumetad methionil, also known as mGlu2/3, for the treatment of patients suffering from schizophrenia.

30 Aug 2012

Technology News and Research

Study may spur research into multi-model imaging based biomarker development for AD

Scientists identify specific role of RESA protein in modulating blood circulation

Astellas Pharma adopts Advantest’s terahertz spectroscopic imaging system TAS7500

Glaucoma and cell death: an interview with Dr. Vivek Gupta

Soligenix’s RiVax induces greater ricin neutralizing antibody levels in humans

Quest Diagnostics announces availability of TERC test for cervical cancer

MGC Diagnostics third quarter total revenues increase 8% to $6.9 million

Early European TAVI registry data unveiled

New book on medical screening to be launched on Sep. 4

Ambassador Rice lauds India's role in fighting polio, ensuring child survival

Bradykinesia in Parkinson’s disease: an interview with Dr. Joseph Giuffrida, President of Great Lakes NeuroTechnologies

India's contribution to global health R&D needs domestic, international support

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

Octogenarians have better survival rates following heart valve surgery

Johns Hopkins team creates synthetic protein that can help locate tumors

CCE, Accretive Health partner to develop novel oncology care management

UCSF’s intensive care unit study receives $2.1 million Moore Foundation grant

Collegium commences enrollment in Oxycodone DETERx Phase 3 study in chronic lower back pain

Israel's Ministry of Health approves Medgenics’ INFRADURE Phase I/II clinical trials for hepatitis C

Lilly decides to terminate pomaglumetad methionil Phase III trial on schizophrenia

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News